Perceptive Advisors LLC Nuvalent, Inc. Transaction History

Perceptive Advisors LLC

$3 Billion
Q4 2024

A detailed history of Perceptive Advisors LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 2,619,977 shares of NUVL stock, worth $216 Million. This represents 6.84% of its overall portfolio holdings.

Number of Shares

2,619,977

Previous 2,979,235 12.06%

Holding current value

$216 Million

Previous $305 Million 32.71%

% of portfolio

6.84%

Previous 7.96%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$77.87 - $104.93 $28 Million - $37.7 Million	-359,258 Reduced 12.06%	2,619,977 $205 Million
Q3 2024 Nov 14, 2024	BUY	$67.44 - $112.17 $29 Million - $48.3 Million	430,158 Added 16.88%	2,979,235 $305 Million
Q2 2024 Aug 14, 2024	SELL	$62.76 - $81.61 $14.7 Million - $19.1 Million	-234,377 Reduced 8.42%	2,549,077 $193 Million
Q1 2024 May 15, 2024	SELL	$72.35 - $88.99 $9.73 Million - $12 Million	-134,537 Reduced 4.61%	2,783,454 $209 Million
Q4 2023 Feb 14, 2024	BUY	$42.42 - $80.28 $19.3 Million - $36.5 Million	454,540 Added 18.45%	2,917,991 $215 Million
Q3 2023 Nov 14, 2023	BUY	$39.12 - $49.85 $10.5 Million - $13.4 Million	268,630 Added 12.24%	2,463,451 $113 Million
Q2 2023 Aug 14, 2023	SELL	$23.58 - $44.68 $2.48 Million - $4.7 Million	-105,227 Reduced 4.57%	2,194,821 $92.6 Million
Q1 2023 May 15, 2023	BUY	$25.42 - $33.52 $1.14 Million - $1.51 Million	45,041 Added 2.0%	2,300,048 $60 Million
Q4 2022 Feb 14, 2023	BUY	$18.46 - $36.37 $11.1 Million - $21.8 Million	600,000 Added 36.25%	2,255,007 $67.2 Million
Q2 2022 Aug 15, 2022	SELL	$7.4 - $15.07 $714,795 - $1.46 Million	-96,594 Reduced 5.51%	1,655,007 $22.4 Million
Q1 2022 May 16, 2022	BUY	$11.65 - $19.57 $11.7 Million - $19.6 Million	1,001,601 Added 133.55%	1,751,601 $24.3 Million
Q3 2021 Nov 15, 2021	BUY	$18.25 - $38.35 $13.7 Million - $28.8 Million	750,000 New	750,000 $16.9 Million

Others Institutions Holding NUVL

# of Institutions

231

Shares Held

58.9M

Call Options Held

834K

Put Options Held

490K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.54B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Nuvalent, Inc. Transaction History